Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates Claims will be eligible for early trial dates, to gauge how juries may respond to more than 1,500 Bard port catheter lawsuits pending in the federal MDL. April 30, 2025 Irvin Jackson Add Your Comments Parties involved in the federal litigation over complications caused by Bard PowerPorts and other implantable port catheter devices have each submitted a list of cases, which they believe are representative candidates for early bellwether trials. The claims raise allegations similar to those presented in nearly 1,500 Bard PowerPort lawsuits being pursued against C.R. Bard and Becton Dickinson in the federal court system, indicating that design defects caused plaintiffs to suffer port catheter infections, device fractures, migration injuries and other serious health problems. Also known as totally implantable vascular access devices (TIVADs), the Bard PowerPort systems have been widely used in recent years to help deliver chemotherapy and other medications directly into a patient’s bloodstream, involving an injection port site where the needle is inserted, and a polyurethane catheter tube that delivers the fluids to the patient’s body. While the Bard implantable port catheters have been sold as safe and effective products, each of the lawsuits allege that the catheter material is prone to degrade and fracture inside the body, potentially resulting in the need for revision surgery to remove the failed device. Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in complaints brought in federal courts nationwide, all Bard PowerPort lawsuits are currently consolidated as part of an MDL, or multidistrict litigation, with U.S. District Judge David G. Campbell presiding over coordinated discovery and pretrial proceedings out of the U.S. District Court for the District of Arizona. Early in the litigation, Judge Campbell established a plan to prepare a group of claims for early test trials, known as “bellwether” cases, which are intended to help the parties evaluate how juries may respond to certain evidence and testimony that could be repeated throughout the lawsuits. In December 2023, the parties selected a group of 24 Bard PowerPort bellwether cases, for an initial pool. After conducting limited discovery, the parties narrowed that list down to 15 Bard PowerPort lawsuits that have gone through more specific preparations over the past six months, and they are now each proposing what they believe are the most suitable trial candidates. On April 28, both plaintiffs (PDF) and defendants (PDF) turned in a list of six cases each. The two lists contain one lawsuit in common, resulting in a total of 11 Bard PowerPort claims for the Court to choose from when scheduling the first trials. “Plaintiffs propose a mix of cases that will be most representative of the full range of devices, claims, and injuries at issue in this MDL. That proposed composition is: three infection cases, two fracture cases, and one thrombosis case,” the plaintiffs’ submission states. “Defendants are in near agreement with Plaintiffs’ proposed composition of injuries. In advance of this filing and in the days since the April 17, 2025 exchange of proposed bellwether trial lists, the parties met and conferred on multiple occasions. Although the parties did not reach complete agreement, they were able to reach agreement on the injury types that should be represented in five of the six trial cases.” According to a joint memorandum (PDF) issued by the parties on April 28, there are currently 1,480 Bard PowerPort lawsuits pending in the MDL. Another 85 claims are part of a multicounty litigation in New Jersey state court, and an additional 15 claims are filed in Maricopa County, in Arizona. Although the outcomes of these early bellwether trials will not have any binding impact on other claims pending in the MDL or state courts, they will be closely watched by lawyers involved in the litigation and the average jury awards are expected to have a major impact on future Bard PowerPort lawsuit settlement negotiations. However, if the bellwether trials do not result in a Bard PowerPort settlement agreement, all of those lawsuits could be remanded back to their originating court districts for hundreds of individual trial dates. Find Out If You Qualify for Port Catheter Compensation Tags: Bard, Bard PowerPort, Becton Dickinson, Catheter, Fracture, Infection, PowerPort Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Bard PowerPort Stories Bard PowerPort Lawsuit MDL Tops 2,000 Cases September 17, 2025 Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 August 26, 2025 Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025 0 Comments InstagramThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025) Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)
Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: yesterday) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 2 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue (Posted: 3 days ago) Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation. MORE ABOUT: OZEMPIC LAWSUITReports of ‘Ozempic Teeth’ Raise Concerns Over Dry Mouth Side Effects Linked to GLP-1s (10/03/2025)Study Raises New Questions Over Ozempic Hair Loss Risks (09/26/2025)Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges (09/24/2025)